Notice of Intent to Sole Source – Trilogy
Closed Special Notice Posted
- Solicitation number
- 25-009972
- Agency
- NIH Clinical Center National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
-
- Kristin Nagashima kristin.nagashima@nih.gov
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center has issued a Notice of Intent to Sole Source award for Red Hat software licenses, services, and support required by the Department of Transfusion Medicine's Center for Cellular Engineering. The procurement is set aside for total small business participation and involves a planned sole source award to Trilogy Innovations, located in Bridgeport, West Virginia. The acquisition falls under Product Service Code 6515 for Medical Instruments, Equipment, and Supplies and NAICS Code 339112 for Surgical and Medical Instrument Manufacturing. Performance will take place in Bethesda, Maryland, with the notice posted on August 22, 2025, and a response deadline of September 11, 2025. This is strictly a notice of intent rather than a solicitation, meaning no formal quotation process will occur.
The procurement's objective is to secure Red Hat OpenShift Kubernetes Engine licenses, Red Hat Enterprise Linux Server licenses with Satellite support, and senior consulting services for a one-year period from October 1, 2025, through September 30, 2026. The NIH intends to utilize FAR Part 13 Simplified Acquisition Procedures, specifically allowing sole source procurement when only one source is reasonably available and the contract value remains below the simplified acquisition threshold. No formal solicitation document will be issued, and contractors cannot submit quotations for this opportunity. The acquisition includes 40 units of Red Hat OpenShift licenses, 6 units of Red Hat Enterprise Linux Server licenses, and 20 hours of senior consulting services. Interested parties should note that this procurement is exempt from standard competition requirements under FAR Part 6 due to its classification under simplified acquisition procedures.
Notice text
This acquisition is for Red Hat Licenses, Services and Support for at the Department of Transfusion Medicine, Center for Cellular Engineering (CCE) at the National Institutes of Health (NIH) Clinical Center (CC).
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 25-009972
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Trilogy Innovations, located at 45 Professional Pl, STE 102, Bridgeport, WV, on a firm fixed price sole source award basis to provide Red Hat software licenses to the National Institutes of Health.
Below is a description of the item(s):
Description: Red Hat OpenShift Kubernetes Engine, Premium, Confirmed Stateside Support (2 Cores, 4 vCPUs or 2 AI Accelerators), 1y Start Date: 10/01/2025 End Date: 09/30/2026 ACCT #: 6088283
Units: Each
Catalog: MW01016
Qty: 40
Description: Red Hat Enterprise Linux Server with Satellite, Premium 1y Start Date: 10/01/2025 End Date: 09/30/2026 ACCT #: 6088283
Units: Each
Catalog: RH00008
Qty: 6
Description: Red Hat Consulting: Senior Consultant, 1y Start Date: 10/01/2025 End Date: 09/30/2026
Units: Hours
Catalog: GPS-SC
Qty: 20
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by September 11, 2025 at 12pm EST.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity